I. Introduction
Gastrin-releasing peptide (GRP) exhibits varieties of physiological functions by binding to the gastrin-releasing peptide receptor (GRPR, also called BB2) [1]. Some evidences in rodents suggested that dysfunctions in GRPR expression and GRP signaling might play a vital in varieties of cognitive function and central nervous system (CNS) disorders such as Parkinson's disease (PD) and Alzheimer's disease (AD) [2]-[5]. Moreover, a recent research indicated that GRP might relate to modulate neuronal and neurogenesis growth and might contribute to hippocampus function [6].